| Registrera dig | Logga in | FAQ | [?] |
A proteomic analysis of cell signaling alterations in colorectal cancerby: Juan Madoz-Gurpide, Marta Canamero, Lydia Sanchez, Jose Solano, Patricia Alfonso, Ignacio J Casal
Mol Cell Proteomics (11 September 2007), M700006-MCP200.
|
Reviews
[Write a review of this article]
There are no reviews of this article
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
ReferatTo gain further insight into alterations in cellular pathways, tumor profiling and marker discovery in colorectal cancer (CRC) we have used a new antibody microarray specific for cell signaling. Soluble protein extracts were prepared from paired tumor/normal biopsies of 11 patients diagnosed of colorectal carcinoma at different stages, four liver carcinomas were used as a reference. Antibody microarray analysis identified 46 proteins that were differentially expressed between normal colorectal epithelium and adenocarcinoma. These proteins gave a specific signature for CRC, different from other tumors, as well as a panel of novel markers and potential targets for CRC. Twenty-four proteins were validated by using a specific colorectal cancer tissue microarray and immunoblotting analysis. Together with some previously well known deregulated proteins in CRC (-catenin, c-myc, or p63), we have found new potential markers preferentially expressed in CRC tumors: cytokeratin 13, calcineurin, Chk1, clathrin light chain, MAPK3, phospho-PTK2/FAK (S910) and MDM2. Chk1 antibodies were particularly effective in discriminating between tumoral and normal mucosa in CRC. Moreover, a global picture of alterations in signaling pathways in CRC was observed, including a significant up-regulation of different components of the EGFR and Wnt/-catenin pathways and the down-regulation of p14ARF. The experimental approach described here should be applicable to other pathologies and neoplasic processes. 10.1074/mcp.M700006-MCP200
BibTeX record
RIS record